13. Type 1 Diabetes Mellitus
Published Online: 23 FEB 2012
DOI: 10.1002/9781119968153.ch13
Copyright © 2012 John Wiley & Sons, Ltd.
Book Title

Handbook of Clinical Pediatric Endocrinology, Second Edition
Additional Information
How to Cite
Brook, C. G. D. and Dattani, M. T. (2012) Type 1 Diabetes Mellitus, in Handbook of Clinical Pediatric Endocrinology, Second Edition, Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781119968153.ch13
Publication History
- Published Online: 23 FEB 2012
- Published Print: 13 APR 2012
ISBN Information
Print ISBN: 9780470657881
Online ISBN: 9781119968153
- Summary
- Chapter
Keywords:
- classification of diabetes;
- complications of diabetes;
- definition of diabetes;
- diabetes mellitus;
- diabetic ketoacidosis;
- diet;
- distinguishing type 1 from type 2 diabetes;
- exercise;
- insulin pumps;
- insulin therapy;
- monitoring diabetic control;
- side-effects of insulin;
- transition to adult care;
- type 1 diabetes;
- type 2 diabetes
Summary
Type 1 diabetes is common. Understanding its pathology is easy but controlling it and preventing complications of diabetes starting in children is formidably difficult. This chapter aims to help. Distinguishing type 1 diabetes mellitus from type 2 diabetes mellitus can be challenging; the presence of autoantibodies and measurable concentrations of C-peptide can aid in the diagnosis. Children with type 1 diabetes mellitus should be treated by a team which includes an endocrinologist, a specialist nurse educator, and a mental health professional. Therapy must be individualized. Type 1 diabetes mellitus should be intensively treated to reduce the incidence and progression of long-term complications. Hypoglycemia is a serious barrier to “tight” control. Diabetic ketoacidosis is a preventable, potentially fatal complication of established diabetes which is most commonly due to omission of insulin or the administration of inadequate insulin during infection. Long-term micro- and macrovascular complications are inevitable but rare before puberty. Screening for them should start within 5 years of the onset of disease and countermeasures be introduced as early as possible.
